Gastric cancer remains a major global health issue, ranking as the fifth most common cancer and the fourth leading cause of cancer-related death worldwide. However, its presence in the United States is somewhat misleading. While overall incidence appears relatively low, this average obscures significant disparities. Certain subpopulations, including individuals of East Asian, Hispanic, and Eastern European ancestry, experience substantially higher risk. In these groups, incidence rates approach those seen in higher- prevalence regions, raising important questions about whether risk-based screening and prevention strategies should be more systematically implemented.

On March 10, 2026, more than 70 attendees, including patients, advocates, physicians, researchers, and policymakers, gathered at the Cannon House Office Building in Washington, D.C., for the second Congressional forum organized by the Stomach Cancer Task Force. Building on its inaugural 2024 meeting, this year’s forum focused on gastric cancer prevention in high-risk populations and the policy pathways needed to support it.

The event was held in collaboration with the Yale Gastric Cancer Prevention and Screening Program, reflecting a growing effort to bridge academic research, clinical practice, and national policy discussions.

The forum also took place at a pivotal moment in policy development. In August 2025, the Stomach Cancer Prevention and Early Detection Act was introduced by Representatives Judy Chu and Joe Wilson. The bill represents an important step toward advancing national awareness, strengthening research efforts, and beginning to define a framework for early detection in the United States. While still in early stages, it signals growing recognition that gastric cancer requires a more structured approach to risk identification and prevention, particularly for populations that remain disproportionately affected.

A Disease of Late Diagnosis and Missed Opportunities

A recurring theme throughout the forum was that gastric cancer in the United States is too often diagnosed at advanced stages not because preventive tools are lacking, but because they are not systematically used. Prevention remains largely symptom-driven rather than risk-based, leading to missed opportunities for early intervention.

This disconnect set the stage for a series of presentations that examined gastric cancer from clinical, surgical, patient, and policy perspectives.

Perspectives from the Frontlines

Community and Clinical Realities

Dr. Mun Hong presented a community gastroenterology perspective, highlighting the realities faced in high-risk populations. He emphasized variability in awareness, access, and implementation of preventive strategies such as Helicobacter pylori testing and endoscopic evaluation. His remarks reinforced that risk is often present but not systematically identified in routine clinical care.

Surgical Consequences of Late Detection

Dr. Haejin In focused on the surgical impact of gastric cancer, illustrating how late-stage diagnosis limits treatment options and worsens outcomes. From a surgical standpoint, earlier detection fundamentally changes the trajectory of care by determining whether patients are candidates for curative intervention.

Advances and Limits in Treatment

Dr. Reetu Mukherji discussed progress and challenges in advanced gastric cancer, noting that while systemic therapies have improved, they remain limited in their ability to significantly alter outcomes for patients diagnosed at late stages. Her presentation reinforced the need to shift attention earlier in the disease process.

The Patient Perspective

A particularly powerful perspective came from Aki Smith, a patient advocate and founder of Hope for Stomach Cancer, who shared the human impact of delayed diagnosis. Her remarks highlighted how gaps in awareness, access, and timely evaluation translate directly into patient experiences, often with profound consequences.

From Late Diagnosis to Prevention

Dr. Chul Hyun framed the broader issue as a systems- level failure in prevention. He emphasized that although risk factors and early disease markers are well understood, they are not consistently translated into clinical action. The challenge lies not in knowledge, but in implementation.

Key Questions from the Audience

The forum concluded with a dynamic question and answer session,thoughtfullymoderatedbyDr. McMenamin,whose efforts helped facilitate a lively and productive discussion among panelists and attendees.

Audience engagement reflected both interest and urgency, with several themes emerging repeatedly.

Participants discussed the role of Helicobacter pylori screening in high-risk populations, recognizing it as a key modifiable risk factor but also acknowledging that its use in U.S. practice remains inconsistent. Questions centered on how to expand testing in primary care settings and how to align coverage and guidelines with prevention goals.

There was also active discussion about the role of endoscopic screening, particularly in individuals with identifiable risk factors such as ethnicity, family history, or geographic background. While such approaches are standard in high- incidence countries, the United States lacks clear and operational pathways to implement risk-based endoscopic strategies.

Bridging the Policy Gap

Across discussions, a central insight emerged. The challenge is not a lack of knowledge, but a lack of systems that translate risk into action.

The introduction of the Stomach Cancer Prevention and Early Detection Act reflects growing recognition that gastric cancer requires a more coordinated prevention strategy. By advancing awareness, research priorities, and early detection efforts, the legislation represents an initial step toward building a framework that could support risk-based screening and more systematic prevention in the future.

Key policy considerations discussed at the forum included improving risk identification through better data capture such as ethnicity and country of origin, expanding access to Helicobacter pylori testing and treatment, clarifying indications for risk-based endoscopy, embedding clinical decision support into routine workflows, and addressing structural barriers including access to care, language, and health literacy. These are not distant goals but actionable steps that can be implemented within existing healthcare systems if supported by appropriate incentives and infrastructure.

Looking Ahead

The 2026 Congressional forum underscored a critical shift in thinking. Gastric cancer should no longer be viewed solely as a disease of treatment, but as one of missed prevention opportunities.

By bringing together voices from across medicine, advocacy, and policy, the forum highlighted a path forward that prioritizes early detection, risk-based care, and system- level change. As discussions continue, the challenge remains clear. The next step is to move from awareness to implementation and from late diagnosis to prevention.